RAPT Therapeutics Announces Proposed Public Offering of Common Stock on October 23, 2025 Biological Factors conditions Dilution technique Gross (qualifier value) Immunology Market Pricing public entity RAPT +
Moderna's COVID Vaccine Wins FDA Approval for At-Risk Young Children on July 12, 2025 Approved at-risk Child conditions Covid vaccine Moderna Spikevax United States Food and Drug Administration +
Moderna’s Next-Generation COVID Shot Gets FDA Backing With Usage Limitations on June 02, 2025 age restriction Approved conditions COVID19 (disease) Effectiveness mNEXSPIKE Moderna mRNA-1283 next-generation vaccine respiratory virus season United States Food and Drug Administration Vaccines +
Galapagos Reconsiders Company Split After Market Developments on May 13, 2025 Cell Therapy Company Split conditions Drug Development Galapagos leadership change Market strategic review +